Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Prostate Cancer

  Free Subscription


Articles published in Int J Radiat Oncol Biol Phys

Retrieve available abstracts of 107 articles:
HTML format



Single Articles


    November 2021
  1. ENNIS RD, Vapiwala N
    The Fallacy of the Consultation and Informed Consent Process in Radiation Oncology Through the Lens of Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111:643-646.
    PubMed    


    October 2021
  2. MUSUNURU HB, Cheung P, Vesprini D, Liu SK, et al
    Gantry-based 5-fraction Elective Nodal Irradiation in Unfavorable-Risk Prostate Cancer: Outcomes from 2 Prospective Studies comparing SABR Boost with MR Dose Painted HDR Brachytherapy Boost.
    Int J Radiat Oncol Biol Phys. 2021 Oct 9. pii: S0360-3016(21)02899.
    PubMed     Abstract available


    September 2021
  3. JONES CU, Pugh SL, Sandler HM, Chetner MP, et al
    Adding short-term androgen deprivation therapy to RT in men with localized prostate cancer: long-term update of the NRG/RTOG 9408 randomized clinical trial.
    Int J Radiat Oncol Biol Phys. 2021 Sep 1. pii: S0360-3016(21)02724.
    PubMed     Abstract available


  4. NAGAR H, Spratt DE
    Prostate SBRT Dose Escalation (9 Gyx5, 13.3 Gyx3, 24 Gyx1): Are We Making Progress?
    Int J Radiat Oncol Biol Phys. 2021;111:110-112.
    PubMed    


    August 2021
  5. NUIJENS AC, Oei AL, van Oorschot B, Visser J, et al
    Gamma-H2AX Foci Decay Ratio as a Stronger Predictive Factor of Late Radiation Toxicity than Dose-Volume Parameters in a Prospective Cohort of Prostate Cancer Patients.
    Int J Radiat Oncol Biol Phys. 2021 Aug 19. pii: S0360-3016(21)02708.
    PubMed     Abstract available


  6. FERREIRA MR, Sands CJ, Li JV, Andreyev JN, et al
    Impact of pelvic radiotherapy for prostate cancer on global metabolic profiles and microbiota-driven gastrointestinal late side-effects: a longitudinal observational study.
    Int J Radiat Oncol Biol Phys. 2021 Aug 2. pii: S0360-3016(21)02626.
    PubMed     Abstract available


  7. LEITE ETT, Ramos CCA, Moraes FY
    In Reply to Fiorino et al.
    Int J Radiat Oncol Biol Phys. 2021;110:1549-1550.
    PubMed    


  8. ARAI TJ, Yang DM, Campbell JW 3rd, Chiu T, et al
    Oxygen-Sensitive MRI: A Predictive Imaging Biomarker for Tumor Radiation Response?
    Int J Radiat Oncol Biol Phys. 2021;110:1519-1529.
    PubMed     Abstract available


  9. PRASANNA PG, Rawojc K, Guha C, Buchsbaum JC, et al
    Normal Tissue Injury Induced by Photon and Proton Therapies: Gaps and Opportunities.
    Int J Radiat Oncol Biol Phys. 2021;110:1325-1340.
    PubMed     Abstract available


    July 2021
  10. PARZEN JS, Hamstra DA
    Patient-Reported Quality of Life During Prostate Cancer Radiation Therapy: Insights Into the Patient Experience.
    Int J Radiat Oncol Biol Phys. 2021;110:1129-1131.
    PubMed    


  11. CHOUDHURY A, Henry Md Frcr A, Mitin Md PhD T, Chen Md Mph R, et al
    Photons, Protons, SBRT, Brachytherapy-What Is Leading the Charge for the Management of Prostate Cancer? A Perspective From the GU Editorial Team.
    Int J Radiat Oncol Biol Phys. 2021;110:1114-1121.
    PubMed    


  12. EFSTATHIOU JA, Kamran SC, Spratt DE
    Protons Versus Photons for Prostate Cancer: An Answer That Is Long Overdue and Coming.
    Int J Radiat Oncol Biol Phys. 2021;110:1098-1100.
    PubMed    


  13. PARKER C
    Timing of Postoperative Radiation Therapy After Radical Prostatectomy.
    Int J Radiat Oncol Biol Phys. 2021;110:1132-1134.
    PubMed    


  14. YANG Y, Vargas CE, Bhangoo RS, Wong WW, et al
    Exploratory Investigation of Dose-Linear Energy Transfer (LET) Volume Histogram (DLVH) for Adverse Events Study in Intensity Modulated Proton Therapy (IMPT).
    Int J Radiat Oncol Biol Phys. 2021;110:1189-1199.
    PubMed     Abstract available


  15. SCHUMACHER O, Luo H, Taaffe DR, Galvao DA, et al
    Effects of exercise during radiotherapy on physical function and treatment-related side effects in men with prostate cancer: a systematic review and meta-analysis.
    Int J Radiat Oncol Biol Phys. 2021 Jul 8. pii: S0360-3016(21)00841.
    PubMed     Abstract available


  16. BERTHOLD J, Khamfongkhruea C, Petzoldt J, Thiele J, et al
    First-in-human validation of CT-based proton range prediction using prompt gamma imaging in prostate-cancer treatments.
    Int J Radiat Oncol Biol Phys. 2021 Jul 3. pii: S0360-3016(21)00843.
    PubMed     Abstract available


  17. KISHAN AU, Collins SP
    Quality of Life After Prostate Cancer Treatment.
    Int J Radiat Oncol Biol Phys. 2021;110:727-730.
    PubMed    


  18. MOHAMAD O, Feng F
    Treating Localized High-Risk Prostate Cancer: Do All Roads Lead to Rome?
    Int J Radiat Oncol Biol Phys. 2021;110:634-635.
    PubMed    


  19. BELKACEMI Y, Coraggio G, Loganadane G
    Management Strategy of High-Risk Localized Prostate Cancer: Is there a Transatlantic Consensus?
    Int J Radiat Oncol Biol Phys. 2021;110:631-632.
    PubMed    


  20. RANS K, De Meerleer G, Joniau S, Baten A, et al
    In Regard to Zelefsky et al.
    Int J Radiat Oncol Biol Phys. 2021;110:910-911.
    PubMed    


  21. WALSHAW RC, Hoskin PJ, Choudhury A
    Can Hypofractionation and Immune Modulation Coexist?
    Int J Radiat Oncol Biol Phys. 2021;110:742-744.
    PubMed    


  22. WALLIS CJD, Klotz L, Satkunasivam R, Klaassen Z, et al
    Not So "Active" Surveillance.
    Int J Radiat Oncol Biol Phys. 2021;110:716-717.
    PubMed    


  23. SHORTALL J, Palma G, Mistry H, Vasquez Osorio E, et al
    Flogging a Dead Salmon? Reduced Dose Posterior to Prostate Correlates With Increased PSA Progression in Voxel-Based Analysis of 3 Randomized Phase 3 Trials.
    Int J Radiat Oncol Biol Phys. 2021;110:696-699.
    PubMed    


  24. CHEN RC
    A Trans-Atlantic Voyage of Extended ADT With Local Radiation.
    Int J Radiat Oncol Biol Phys. 2021;110:633.
    PubMed    


  25. VAN DAMS R, Jiang NY, Fuller DB, Loblaw A, et al
    Stereotactic Body Radiotherapy for High-Risk Localized Carcinoma of the Prostate (SHARP) Consortium: Analysis of 344 Prospectively Treated Patients.
    Int J Radiat Oncol Biol Phys. 2021;110:731-737.
    PubMed     Abstract available


  26. HSU IC, Rodgers JP, Shinohara K, Purdy J, et al
    Long-Term Results of NRG Oncology/RTOG 0321: A Phase II Trial of Combined High Dose Rate Brachytherapy and External Beam Radiation Therapy for Adenocarcinoma of the Prostate.
    Int J Radiat Oncol Biol Phys. 2021;110:700-707.
    PubMed     Abstract available


    June 2021
  27. BRAND DH, Bruningk SC, Wilkins A, Fernandez K, et al
    Estimates of Alpha/Beta (alpha/beta) Ratios for Individual Late Rectal Toxicity Endpoints: An Analysis of the CHHiP Trial.
    Int J Radiat Oncol Biol Phys. 2021;110:596-608.
    PubMed     Abstract available


    May 2021
  28. NITHIYANANTHAN K, Creighton N, Currow D, Martin JM, et al
    Population-Level Uptake of Moderately Hypofractionated Definitive Radiotherapy in the Treatment of Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2021 May 8. pii: S0360-3016(21)00460.
    PubMed     Abstract available


  29. HARA D, Tao W, Totiger T, Pourmand A, et al
    Prostate Cancer Targeted X-ray Fluorescence Imaging via Gold Nanoparticles Functionalized with Prostate-Specific Membrane Antigen (PSMA).
    Int J Radiat Oncol Biol Phys. 2021 May 5. pii: S0360-3016(21)00459.
    PubMed     Abstract available


  30. WANG K, Mavroidis P, Royce TJ, Falchook AD, et al
    Prostate Stereotactic Body Radiation Therapy: An Overview of Toxicity and Dose Response.
    Int J Radiat Oncol Biol Phys. 2021;110:237-248.
    PubMed     Abstract available


    April 2021
  31. NABID A, Carrier N, Vigneault E, Van Nguyen T, et al
    OPTIMIZING TREATMENT IN INTERMEDIATE RISK PROSTATE CANCER: SECONDARY ANALYSIS OF A RANDOMIZED PHASE III TRIAL.
    Int J Radiat Oncol Biol Phys. 2021 Apr 23. pii: S0360-3016(21)00373.
    PubMed     Abstract available


  32. MASTERS SC, Hofling AA, Gorovets A, Marzella L, et al
    FDA Approves Ga 68 PSMA-11 for Prostate Cancer Imaging.
    Int J Radiat Oncol Biol Phys. 2021 Apr 12. pii: S0360-3016(21)00357.
    PubMed    


  33. YAMAZAKI H, Suzuki G, Aibe N, Yoshida K, et al
    Posterior Margins in Prostate Cancer Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2021;109:1657-1658.
    PubMed    


  34. MITCHELL D, Jain S
    Brachytherapy Boost in Prostate Cancer: What Does Observational Data Add to the Debate?
    Int J Radiat Oncol Biol Phys. 2021;109:1230-1231.
    PubMed    


  35. LEITE ETT, Ramos CCA, Ribeiro VAB, Salvajoli BP, et al
    Hypofractionated Radiation Therapy to the Prostate Bed With Intensity-Modulated Radiation Therapy (IMRT): A Phase 2 Trial.
    Int J Radiat Oncol Biol Phys. 2021;109:1263-1270.
    PubMed     Abstract available


  36. FU SY, Chen FH, Wang CC, Yu CF, et al
    Role of Myeloid-Derived Suppressor Cells in High-Dose-Irradiated TRAMP-C1 Tumors: A Therapeutic Target and an Index for Assessing Tumor Microenvironment.
    Int J Radiat Oncol Biol Phys. 2021;109:1547-1558.
    PubMed     Abstract available


  37. ROBIN S, Jolicoeur M, Palumbo S, Zilli T, et al
    Prostate Bed Delineation Guidelines for Postoperative Radiation Therapy: On Behalf Of The Francophone Group of Urological Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2021;109:1243-1253.
    PubMed     Abstract available


    March 2021
  38. FOLKERT MR, Zelefsky MJ, Hannan R, Desai NB, et al
    A Multi-Institutional Phase II Trial of High-Dose SAbR for Prostate Cancer Using Rectal Spacer.
    Int J Radiat Oncol Biol Phys. 2021 Mar 19. pii: S0360-3016(21)00285.
    PubMed     Abstract available


  39. MAGLI A, Farneti A, Faiella A, Ferriero M, et al
    Toxicity at 1 year after Stereotactic Body Radiotherapy in 3 Fractions for Localized Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2021 Mar 18. pii: S0360-3016(21)00287.
    PubMed     Abstract available


  40. BUSZEK SM, Ludmir EB, Grosshans DR, McAleer MF, et al
    Disease Control and Patterns of Failure After Proton Beam Therapy for Rhabdomyosarcoma.
    Int J Radiat Oncol Biol Phys. 2021;109:718-725.
    PubMed     Abstract available


  41. SHAHI J, Poon I, Ung YC, Tsao M, et al
    Stereotactic Body Radiation Therapy for Mediastinal and Hilar Lymph Node Metastases.
    Int J Radiat Oncol Biol Phys. 2021;109:764-774.
    PubMed     Abstract available


    February 2021
  42. BUBLEY GJ, Kaplan I, Bhatt R, Taplin ME, et al
    Phase II study of Enzalutamide with radiation therapy for intermediate risk prostate cancer: A phase 2 study.
    Int J Radiat Oncol Biol Phys. 2021 Feb 23. pii: S0360-3016(21)00205.
    PubMed     Abstract available


  43. KUBES J, Haas A, Vondracek V, Andrlik M, et al
    Ultra-hypofractionated proton radiotherapy in the treatment of low- and intermediate-risk prostate cancer - 5-years outcomes.
    Int J Radiat Oncol Biol Phys. 2021 Feb 12. pii: S0360-3016(21)00189.
    PubMed     Abstract available


  44. VAPIWALA N, Wong JK, Handorf E, Paly J, et al
    A Pooled Toxicity Analysis of Moderately Hypofractionated Proton Beam Therapy and Intensity-Modulated Radiation Therapy in Early Stage Prostate Cancer Patients.
    Int J Radiat Oncol Biol Phys. 2021 Feb 1. pii: S0360-3016(21)00117.
    PubMed     Abstract available


  45. SUD S, Gerringer BC, Wacaser B, Tan X, et al
    Under-ascertainment of clinically-meaningful symptoms during prostate cancer radiation therapy - does this vary by patient characteristics?
    Int J Radiat Oncol Biol Phys. 2021 Feb 1. pii: S0360-3016(21)00108.
    PubMed     Abstract available


    January 2021
  46. ROY S, Grimes S, Morgan SC, Eapen L, et al
    Patient-reported Outcomes from a Phase III Randomized Controlled Trial Exploring Optimal Sequencing of Short-term Androgen Deprivation Therapy with Prostate Radiotherapy in Localized Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2021 Jan 29. pii: S0360-3016(21)00092.
    PubMed     Abstract available


  47. CHEN RC, Prime SG, Basak R, Moon DH, et al
    Receipt of guideline-recommended surveillance in a population-based cohort of active surveillance prostate cancer patients.
    Int J Radiat Oncol Biol Phys. 2021 Jan 13. pii: S0360-3016(21)00034.
    PubMed     Abstract available


    December 2020
  48. GARIN O, Suarez JF, Guedea F, Pont A, et al
    Comparative Effectiveness Research in Localized Prostate Cancer: a 10-Year follow-up Cohort Study.
    Int J Radiat Oncol Biol Phys. 2020 Dec 31. pii: S0360-3016(20)34728.
    PubMed     Abstract available


  49. CHEN WC, Li Y, Lazar A, Altan A, et al
    Stereotactic body radiotherapy and high-dose rate brachytherapy boost in combination with intensity modulated radiotherapy for localized prostate cancer: a single-institution propensity score matched analysis.
    Int J Radiat Oncol Biol Phys. 2020 Dec 29. pii: S0360-3016(20)34730.
    PubMed     Abstract available


  50. TANG C, Lei X, Smith GL, Pan HY, et al
    Influence of Geography on Prostate Cancer Treatment.
    Int J Radiat Oncol Biol Phys. 2020 Dec 11. pii: S0360-3016(20)34595.
    PubMed     Abstract available


  51. PARRY MG, Nossiter J, Sujenthiran A, Cowling TE, et al
    Impact of high-dose rate and low-dose rate brachytherapy boost on toxicity, functional and cancer outcomes in patients receiving external beam radiation therapy for prostate cancer: a national population-based study.
    Int J Radiat Oncol Biol Phys. 2020 Dec 3. pii: S0360-3016(20)34545.
    PubMed     Abstract available


  52. DEE EC, Muralidhar V, Arega MA, Kishan AU, et al
    Factors influencing non-completion of radiotherapy among men with localized prostate cancer.
    Int J Radiat Oncol Biol Phys. 2020 Dec 1. pii: S0360-3016(20)34604.
    PubMed     Abstract available


  53. JANI A, Schreibmann E, Goyal S, Raghuveer H, et al
    Initial Report of a Randomized Trial Comparing Conventional- vs Conventional plus Fluciclovine ((18)F) PET/CT Imaging-Guided Post-Prostatectomy Radiotherapy for Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2020;108:1397.
    PubMed    


  54. MARCELLO M, Denham JW, Kennedy A, Haworth A, et al
    Reduced Dose Posterior to Prostate Correlates With Increased PSA Progression in Voxel-Based Analysis of 3 Randomized Phase 3 Trials.
    Int J Radiat Oncol Biol Phys. 2020;108:1304-1318.
    PubMed     Abstract available


    November 2020
  55. KOONTZ BF, Hoffman KE, Halabi S, Healy P, et al
    Combination of Radiotherapy and Short-Term Androgen Blockade with Abiraterone Acetate plus Prednisone for Men with High and Intermediate Risk Localized Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2020 Nov 28. pii: S0360-3016(20)34599.
    PubMed     Abstract available


  56. WAGES NA, Sanders JC, Smith A, Wood S, et al
    Hypofractionated post-prostatectomy radiotherapy for prostate cancer to reduce toxicity and improve patient convenience: A Phase I/II trial.
    Int J Radiat Oncol Biol Phys. 2020 Nov 20. pii: S0360-3016(20)34497.
    PubMed     Abstract available


  57. SPENCER KL, Tree AC
    Commentary on Cost-Effectiveness of Metastasis-Directed Therapy in Oligorecurrent Hormone-Sensitive Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2020;108:927-929.
    PubMed    


  58. DESAI NB, Garant A, Hannan R, Folkert MR, et al
    Evolving Brachytherapy Boost in Prostate Cancer in the Era of Hypofractionation.
    Int J Radiat Oncol Biol Phys. 2020;108:914-916.
    PubMed    


  59. BOHMER D, Hocht S, Wiegel T
    Moving Beyond the Hazard Ratio to Personalized Therapy: Is it Prime Time?
    Int J Radiat Oncol Biol Phys. 2020;108:903-904.
    PubMed    


  60. SHI J, Xu K, Keyvanloo A, Udayakumar TS, et al
    A Multimodality Image Guided Precision Radiation Research Platform: Integrating X-ray, Bioluminescence, and Fluorescence Tomography With Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2020;108:1063-1072.
    PubMed     Abstract available


  61. TABRIZI S, Alshalalfa M, Mahal BA, Davicioni E, et al
    Doublecortin Expression in Prostate Adenocarcinoma and Neuroendocrine Tumors.
    Int J Radiat Oncol Biol Phys. 2020;108:936-940.
    PubMed     Abstract available


  62. TAKAGI M, Demizu Y, Fujii O, D KT, et al
    Proton Therapy for Localized Prostate Cancer: Long-term Results in 2,021 Patients.
    Int J Radiat Oncol Biol Phys. 2020 Nov 10. pii: S0360-3016(20)34493.
    PubMed     Abstract available


  63. GOGINENI E, Rana Z, Soberman D, Sidiqi B, et al
    Biochemical control and toxicity outcomes of SBRT vs LDR brachytherapy in the treatment of low and intermediate risk prostate cancer.
    Int J Radiat Oncol Biol Phys. 2020 Nov 7. pii: S0360-3016(20)34489.
    PubMed     Abstract available


  64. BERK L, Lopez Alfonso JC
    Diminishing Returns From Ultrahypofractionated Radiation Therapy for Prostate Cancer In Regard to Vogelius et al.
    Int J Radiat Oncol Biol Phys. 2020;108:834.
    PubMed    


  65. THOMPSON AB, Hamstra DA
    Rectal Spacer Usage with Proton Radiation Therapy for Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2020;108:644-648.
    PubMed    


  66. VOGELIUS IR, Bentzen SM
    In Reply to Berk and Alfonso.
    Int J Radiat Oncol Biol Phys. 2020;108:834-835.
    PubMed    


  67. GUTIONTOV SI, Pitroda SP, Weichselbaum RR
    Oligometastasis: Past, Present, Future.
    Int J Radiat Oncol Biol Phys. 2020;108:530-538.
    PubMed     Abstract available


  68. MAO X, Pineau J, Keyes R, Enger SA, et al
    RapidBrachyDL: Rapid Radiation Dose Calculations in Brachytherapy Via Deep Learning.
    Int J Radiat Oncol Biol Phys. 2020;108:802-812.
    PubMed     Abstract available


    October 2020
  69. HOFFMAN KE
    Wait and Hurry Up: Radiation Therapy for Prostate Cancer During the COVID-19 Pandemic.
    Int J Radiat Oncol Biol Phys. 2020;108:340.
    PubMed    


  70. LEEMAN JE, Nguyen PL
    Less Is More During COVID 19.
    Int J Radiat Oncol Biol Phys. 2020;108:339.
    PubMed    


  71. SPRATT DE
    Cancer Treatment Decision-Making During the COVID-19 Pandemic: Data Over Opinion.
    Int J Radiat Oncol Biol Phys. 2020;108:338-339.
    PubMed    


  72. MOHAMAD O, Roach M 3rd
    Delaying Dilemmas: Coronavirus Complications Impacting the Management of Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2020;108:337.
    PubMed    


  73. LING DC, Vargo JA, Beriwal S
    Breast, Prostate, and Rectal Cancer: Should 5-5-5 Be a New Standard of Care?
    Int J Radiat Oncol Biol Phys. 2020;108:390-393.
    PubMed    


  74. ZAORSKY NG
    Prostate and Pelvis on Pause Pending a Pandemic.
    Int J Radiat Oncol Biol Phys. 2020;108:341-342.
    PubMed    


  75. KOONTZ BF
    Through COVID-Colored Glasses: New Perspectives on Same Data.
    Int J Radiat Oncol Biol Phys. 2020;108:338.
    PubMed    


    September 2020
  76. SANDERS JW, Venkatesan AM, Levitt CA, Bathala T, et al
    Fully balanced SSFP without an endorectal coil for post-implant QA of MRI-assisted radiosurgery (MARS) of prostate cancer: a prospective study.
    Int J Radiat Oncol Biol Phys. 2020 Sep 24. pii: S0360-3016(20)34342.
    PubMed     Abstract available


  77. SPRATT DE, Tward JD
    Absolute versus Relative Benefit of Androgen Deprivation Therapy for Prostate Cancer: Moving Beyond the Hazard Ratio to Personalize Therapy.
    Int J Radiat Oncol Biol Phys. 2020 Sep 11. pii: S0360-3016(20)31252.
    PubMed    


  78. ROYCE TJ, Mavroidis P, Wang K, Falchook AD, et al
    Tumor Control Probability Modeling and Systematic Review of the Literature of Stereotactic Body Radiation Therapy for Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2020 Sep 5. pii: S0360-3016(20)34102.
    PubMed     Abstract available



  79. Erratum to: Pollack A, Chinea FM, Bossart E, Kwon D, Abramowitz MC, Lynne C, Jorda M, Marples B, Patel VN, Wu XD, Reis I, Studenski MT, Casillas J, Stoyanova R. Phase I Trial of MRI-Guided Prostate Cancer Lattice Extreme Ablative Dose (LEAD) Boost Rad
    Int J Radiat Oncol Biol Phys. 2020;108:328.
    PubMed    


    August 2020
  80. HALL WA, Paulson E, Davis BJ, Spratt DE, et al
    NRG Oncology Updated International Consensus Atlas on Pelvic Lymph Node Volumes for Intact and Post-Operative Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2020 Aug 27. pii: S0360-3016(20)34124.
    PubMed     Abstract available


  81. DEEK MP, Taparra K, Dao D, Chan L, et al
    Patterns of Recurrence and Modes of Progression Following Metastasis Directed Therapy in Oligometastatic Castration Sensitive Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2020 Aug 13. pii: S0360-3016(20)34120.
    PubMed     Abstract available


  82. PALY J, Horwitz EM
    Less Is More: Treatment of Locally Advanced Small Cell Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2020;107:865-866.
    PubMed    


  83. DALWADI SM, Zhu A
    Big Small Cell Dilemma.
    Int J Radiat Oncol Biol Phys. 2020;107:863-864.
    PubMed    


  84. ABU-GHEIDA I, Bathala TK, Maldonado JA, Khan M, et al
    Increased Frequency of Mesorectal and Perirectal LN Involvement in T4 Prostate Cancers.
    Int J Radiat Oncol Biol Phys. 2020;107:982-985.
    PubMed     Abstract available


    July 2020
  85. PARRY MG, Nossiter J, Cowling TE, Sujenthiran A, et al
    Toxicity of pelvic lymph node irradiation with intensity modulated radiation therapy for high-risk and locally advanced prostate cancer: a national population-based study using patient-reported outcomes.
    Int J Radiat Oncol Biol Phys. 2020 Jul 24. pii: S0360-3016(20)31450.
    PubMed     Abstract available


  86. MITIN T, Choudhury A
    Flattening the Curve of Prostate Cancer Progression: Accurate Detection and Safe Ablation.
    Int J Radiat Oncol Biol Phys. 2020;107:609-612.
    PubMed    


  87. WANG Y, Chen H
    In Reply to Ghadjar et al.
    Int J Radiat Oncol Biol Phys. 2020;107:856.
    PubMed    


  88. MYLONA E, Ebert M, Kennedy A, Joseph D, et al
    Rectal and Urethro-vesical Subregions for Toxicity Prediction After Prostate Cancer Radiotherapy: validation of voxel-based models in an independent population.
    Int J Radiat Oncol Biol Phys. 2020 Jul 13. pii: S0360-3016(20)31417.
    PubMed     Abstract available


  89. BERGAMIN S, Eade T, Kneebone A, Booth J, et al
    Interim results of a prospective PSMA-directed focal stereotactic re-irradiation trial for locally recurrent prostate cancer.
    Int J Radiat Oncol Biol Phys. 2020 Jul 10. pii: S0360-3016(20)31412.
    PubMed     Abstract available


  90. SANDERS JW, Lewis GD, Thames HD, Kudchadker RJ, et al
    Machine segmentation of pelvic anatomy in MRI-assisted radiosurgery (MARS) for prostate cancer brachytherapy.
    Int J Radiat Oncol Biol Phys. 2020 Jul 4. pii: S0360-3016(20)31396.
    PubMed     Abstract available


  91. VAN SCHIE MA, Janssen TM, Eekhout D, Walraven I, et al
    Knowledge-based assessment of focal dose escalation treatment plans in prostate cancer.
    Int J Radiat Oncol Biol Phys. 2020 Jul 3. pii: S0360-3016(20)31392.
    PubMed     Abstract available


    June 2020
  92. ROY S, Grimes S, Eapen L, Spratt DE, et al
    Impact of Sequencing of Androgen Suppression and Radiotherapy on Testosterone Recovery in Localized Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2020 Jun 18. pii: S0360-3016(20)31258.
    PubMed     Abstract available


  93. PARIKH NR, Kishan AU, Kane N, Diaz-Perez S, et al
    Phase I Trial of Stereotactic Body Radiotherapy Neoadjuvant to Radical Prostatectomy for Patients with High-Risk Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2020 Jun 17. pii: S0360-3016(20)31251.
    PubMed     Abstract available


  94. PARIKH NR, Chang EM, Nickols NG, Rettig MB, et al
    Cost-effectiveness of metastasis-directed therapy in oligorecurrent hormone-sensitive prostate cancer.
    Int J Radiat Oncol Biol Phys. 2020 Jun 13. pii: S0360-3016(20)31250.
    PubMed     Abstract available


  95. JACCARD M, Zilli T, Dubouloz A, Escude L, et al
    Urethra-sparing stereotactic body radiotherapy for prostate cancer: quality assuranceof a randomized phase II trial.
    Int J Radiat Oncol Biol Phys. 2020 Jun 11. pii: S0360-3016(20)31242.
    PubMed     Abstract available


  96. KOLLMEIER MA, McBride S, Varghese M, Debonis D, et al
    Low dose rate brachytherapy combined with ultra-hypofractionated radiation therapy for clinically localized, intermediate-risk prostate cancer: Results from a prospective trial.
    Int J Radiat Oncol Biol Phys. 2020 Jun 4. pii: S0360-3016(20)31189.
    PubMed    



  97. Erratum to: Liu W, Zukotynski K, Emmett L, Chung HT, Chung P, Wolfson R, Rachinsky I, Kapoor A, Metser U, Loblaw A, Morton G, Sexton T, Lock M, Helou J, Berlin A, Boylan C, Archer S, Pond GR, Bauman G. A Prospective Study of 18F-DCFPyL PSMA PET/CT Res
    Int J Radiat Oncol Biol Phys. 2020;107:390.
    PubMed    


  98. YUCE SARI S, Elmali A, Arslan S, Ozyigit G, et al
    In Regard to Aksnessaetheret al.
    Int J Radiat Oncol Biol Phys. 2020;107:387-388.
    PubMed    


  99. CHIN S, Fatimilehin A, Walshaw R, Argarwal A, et al
    Ten-Year Outcomes of Moderately Hypofractionated Salvage Postprostatectomy Radiation Therapy and External Validation of a Contemporary Multivariable Nomogram for Biochemical Failure.
    Int J Radiat Oncol Biol Phys. 2020;107:288-296.
    PubMed     Abstract available


    May 2020
  100. GHADJAR P, Zwahlen DR, Hayoz S, Aebersold DM, et al
    In Regard to Qi et al.
    Int J Radiat Oncol Biol Phys. 2020;107:224-225.
    PubMed    


  101. GUNTHER JR
    Involved-Site Radiation Therapy if Minimal Toxicity.
    Int J Radiat Oncol Biol Phys. 2020;107:20-21.
    PubMed    


  102. ALAYED Y, Davidson M, Liu S, Chu W, et al
    Evaluating the Tolerability of a Simultaneous Focal Boost to the Gross Tumor in Prostate SABR: A Toxicity and Quality-of-Life Comparison of Two Prospective Trials.
    Int J Radiat Oncol Biol Phys. 2020;107:136-142.
    PubMed     Abstract available


    April 2020
  103. QIN H, Zhang V, Bok RA, Santos RD, et al
    Simultaneous metabolic and perfusion imaging using hyperpolarized (13)C MRI can evaluate early and dose-dependent responses to radiotherapy in a prostate cancer mouse model.
    Int J Radiat Oncol Biol Phys. 2020 Apr 24. pii: S0360-3016(20)31042.
    PubMed     Abstract available


  104. MCCLELLAND S 3RD, Petereit DG
    The Advanced Alternative Payment Model: Catalyst for Prostate Brachytherapy Adoption?
    Int J Radiat Oncol Biol Phys. 2020;106:1104-1105.
    PubMed    


  105. WILKINS A, Naismith O, Brand D, Fernandez K, et al
    Derivation of Dose/Volume Constraints for the Anorectum from Clinician- and Patient-Reported Outcomes in the CHHiP Trial of Radiation Therapy Fractionation.
    Int J Radiat Oncol Biol Phys. 2020;106:928-938.
    PubMed     Abstract available


    March 2020
  106. KEALL P, Nguyen DT, O'Brien R, Hewson E, et al
    Real-Time Image-Guided Ablative Prostate Cancer Radiation Therapy: Results from the TROG 15.01 SPARK Trial.
    Int J Radiat Oncol Biol Phys. 2020 Mar 29. pii: S0360-3016(20)30937.
    PubMed     Abstract available


  107. ACHARD V, Zilli T
    In Regard to Qi et al.
    Int J Radiat Oncol Biol Phys. 2020;106:887-888.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Prostate Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: